CooperCompanies Announces Release Date for Second Quarter 2025
CooperCompanies (Nasdaq: COO) has scheduled its second quarter 2025 financial results announcement for Thursday, May 29, 2025, at 4:15 PM ET. The medical device company will follow the release with a conference call at 5:00 PM ET to discuss financial performance and corporate developments.
Interested parties can join the call using the following details:
- Dial-in number: 800-715-9871
- Conference ID: 1515103
An audio webcast will be available simultaneously, and a replay can be accessed through the company's investor relations website at http://investor.coopercos.com.
CooperCompanies (Nasdaq: COO) ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per giovedì 29 maggio 2025, alle 16:15 ET. L'azienda di dispositivi medici terrà una conference call alle 17:00 ET per discutere delle performance finanziarie e degli sviluppi aziendali.
Chiunque sia interessato può partecipare alla chiamata utilizzando i seguenti dettagli:
- Numero di accesso: 800-715-9871
- ID conferenza: 1515103
Una trasmissione audio in diretta sarà disponibile contemporaneamente e una registrazione potrà essere ascoltata sul sito web delle relazioni con gli investitori all'indirizzo http://investor.coopercos.com.
CooperCompanies (Nasdaq: COO) ha programado el anuncio de los resultados financieros del segundo trimestre de 2025 para el jueves 29 de mayo de 2025 a las 4:15 PM ET. La empresa de dispositivos médicos realizará una llamada conferencia a las 5:00 PM ET para discutir el desempeño financiero y los desarrollos corporativos.
Las personas interesadas pueden unirse a la llamada utilizando los siguientes datos:
- Número de acceso: 800-715-9871
- ID de la conferencia: 1515103
Habrá una transmisión de audio simultánea y se podrá acceder a una repetición a través del sitio web de relaciones con inversores de la empresa en http://investor.coopercos.com.
CooperCompanies (나스닥: COO)는 2025년 2분기 재무 실적 발표를 2025년 5월 29일 목요일 동부시간 오후 4시 15분에 예정하고 있습니다. 의료기기 회사는 발표 후 오후 5시(ET)에 컨퍼런스 콜을 진행하여 재무 성과 및 기업 동향에 대해 논의할 예정입니다.
관심 있는 분들은 다음 정보를 통해 전화 회의에 참여할 수 있습니다:
- 전화 접속 번호: 800-715-9871
- 회의 ID: 1515103
동시에 오디오 웹캐스트가 제공되며, 녹음본은 회사 투자자 관계 웹사이트 http://investor.coopercos.com 에서 다시 들을 수 있습니다.
CooperCompanies (Nasdaq : COO) a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le jeudi 29 mai 2025 à 16h15 ET. La société de dispositifs médicaux tiendra une conférence téléphonique à 17h00 ET pour discuter de la performance financière et des développements de l'entreprise.
Les personnes intéressées peuvent rejoindre l'appel en utilisant les informations suivantes :
- Numéro d'appel : 800-715-9871
- ID de la conférence : 1515103
Un webcast audio sera disponible simultanément, et une rediffusion pourra être consultée via le site web des relations investisseurs de la société à l'adresse http://investor.coopercos.com.
CooperCompanies (Nasdaq: COO) hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für Donnerstag, den 29. Mai 2025, um 16:15 Uhr ET geplant. Das Medizintechnikunternehmen wird im Anschluss um 17:00 Uhr ET eine Telefonkonferenz abhalten, um die finanzielle Leistung und Unternehmensentwicklungen zu besprechen.
Interessierte können der Telefonkonferenz mit folgenden Angaben beitreten:
- Einwahlnummer: 800-715-9871
- Konferenz-ID: 1515103
Ein Audio-Webcast wird gleichzeitig verfügbar sein, und eine Aufzeichnung kann über die Investor-Relations-Website des Unternehmens unter http://investor.coopercos.com abgerufen werden.
- None.
- None.
SAN RAMON, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report second quarter 2025 financial results on Thursday, May 29, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The dial-in number for the call is 800-715-9871 and the conference ID is 1515103. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com.
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 16,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
When will CooperCompanies (COO) release Q2 2025 earnings?
How can investors join CooperCompanies Q2 2025 earnings call?
What time is CooperCompanies (COO) earnings call on May 29, 2025?
Where can I find CooperCompanies (COO) Q2 2025 earnings webcast?
What is the dial-in number for CooperCompanies Q2 2025 earnings call?
